164 related articles for article (PubMed ID: 9707017)
1. Double T cell depletion of bone marrow using sequential positive and negative cell immunoaffinity or CD34+ cell selection followed by Campath-1M; effect on CD34+ cells and progenitor cell recoveries.
Clarke E; Potter MN; Hale G; Waldmann H; Lankester A; Cornish JM; Steward CG; Marks DI; Oakhill A; Pamphilon DH
Bone Marrow Transplant; 1998 Jul; 22(2):117-24. PubMed ID: 9707017
[TBL] [Abstract][Full Text] [Related]
2. Impact on T-cell depletion and CD34+ cell recovery using humanised CD52 monoclonal antibody (CAMPATH-1H) in BM and PSBC collections; comparison with CAMPATH-1M and CAMPATH-1G.
Williams RJ; Clarke E; Blair A; Evely R; Hale G; Waldmann H; Brookes S; Pamphilon DH
Cytotherapy; 2000; 2(1):5-14. PubMed ID: 12042050
[TBL] [Abstract][Full Text] [Related]
3. A laboratory comparison of T cell depletion by CD34+ cell immunoaffinity selection and in vitro Campath-1M treatment: clinical implications for bone marrow transplantation and donor leukocyte therapy.
Clarke E; Potter MN; Oakhill A; Cornish JM; Steward CG; Pamphilon DH
Bone Marrow Transplant; 1997 Oct; 20(7):599-605. PubMed ID: 9337063
[TBL] [Abstract][Full Text] [Related]
4. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: comparison of T cell depletion strategies using different CD34+ selection systems or CAMPATH-1.
Dreger P; Viehmann K; Steinmann J; Eckstein V; Müller-Ruchholtz W; Löffler H; Schmitz N
Exp Hematol; 1995 Feb; 23(2):147-54. PubMed ID: 7530212
[TBL] [Abstract][Full Text] [Related]
5. The effect of T cell depletion with Campath-1M on immune reconstitution after chemotherapy and allogeneic bone marrow transplant as treatment for leukaemia.
Lowdell MW; Craston R; Ray N; Koh M; Galatowicz G; Prentice HG
Bone Marrow Transplant; 1998 Apr; 21(7):679-86. PubMed ID: 9578307
[TBL] [Abstract][Full Text] [Related]
6. Comparison between bone marrow and G-CSF-mobilized peripheral blood allografts undergoing clinical scale CD34+ cell selection.
Hassan HT; Zeller W; Stockschläder M; Krüger W; Hoffknecht MM; Zander AR
Stem Cells; 1996 Jul; 14(4):419-29. PubMed ID: 8843543
[TBL] [Abstract][Full Text] [Related]
7. Positive selection of CD34+ hematopoietic cells using an immunoaffinity column results in T cell-depletion equivalent to elutriation.
Cottler-Fox M; Cipolone K; Yu M; Berenson R; O'Shaughnessy J; Dunbar C
Exp Hematol; 1995 Apr; 23(4):320-2. PubMed ID: 7534711
[TBL] [Abstract][Full Text] [Related]
8. Control of graft-versus-host disease and graft rejection by T cell depletion of donor and recipient with Campath-1 antibodies. Results of matched sibling transplants for malignant diseases.
Hale G; Waldmann H
Bone Marrow Transplant; 1994 May; 13(5):597-611. PubMed ID: 8054913
[TBL] [Abstract][Full Text] [Related]
9. Counterflow centrifugation allows addition of appropriate numbers of T cells to allogeneic marrow and blood stem cell grafts to prevent severe GVHD without substantial loss of mature and immature progenitor cells.
Preijers FW; van Hennik PB; Schattenberg A; Ruijs P; Ploemacher RE; de Witte T
Bone Marrow Transplant; 1999 May; 23(10):1061-70. PubMed ID: 10373074
[TBL] [Abstract][Full Text] [Related]
10. CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells.
Hale G; Jacobs P; Wood L; Fibbe WE; Barge R; Novitzky N; Toit C; Abrahams L; Thomas V; Bunjes D; Duncker C; Wiesneth M; Selleslag D; Hidajat M; Starobinski M; Bird P; Waldmann H
Bone Marrow Transplant; 2000 Jul; 26(1):69-76. PubMed ID: 10918407
[TBL] [Abstract][Full Text] [Related]
11. In vitro T cell depletion using Campath 1M for mismatched BMT for severe combined immunodeficiency (SCID).
Dickinson AM; Reid MM; Abinun M; Peak J; Brigham K; Dunn J; Cant AJ
Bone Marrow Transplant; 1997 Feb; 19(4):323-9. PubMed ID: 9051241
[TBL] [Abstract][Full Text] [Related]
12. Comparison of two different methods for CD34+ selection and T cell depletion in peripheral blood stem cell grafts--our experiences with CellPro, E rosetting and CliniMACS technique.
Poloucková A; Vodvárková A; Kobylka P; Hrubá A; Gasová Z; Marinov I; Fales I; Sedlácek P; Kozák T; Starý J
Neoplasma; 2001; 48(5):374-81. PubMed ID: 11845982
[TBL] [Abstract][Full Text] [Related]
13. Combined CD34 positive plus CD2 negative selection for effective T-cell depletion as GvHD-prophylaxis in HLA-nonidentical blood progenitor cell transplantation.
Wiesneth M; Schreiner T; Friedrich W; Müller S; Maccari B; Erne E; Bischof C; Kubanek B
Transfus Sci; 1996 Dec; 17(4):629-35. PubMed ID: 10168563
[TBL] [Abstract][Full Text] [Related]
14. Purging and haemopoietic progenitor cell selection by CD34+ cell separation.
Krüger W; Gruber M; Hennings S; Fehse N; Fehse B; Gutensohn K; Kröger N; Zander AR
Bone Marrow Transplant; 1998 Apr; 21(7):665-71. PubMed ID: 9578305
[TBL] [Abstract][Full Text] [Related]
15. Autologous and allogeneic transplantation with peripheral blood CD34+ cells: a pediatric experience.
Watanabe T; Kawano Y; Watanabe A; Takaue Y
Haematologica; 1999 Feb; 84(2):167-76. PubMed ID: 10091416
[TBL] [Abstract][Full Text] [Related]
16. Purging in auto- and allografts: monoclonal antibodies which use human complement and other natural effector mechanisms.
Cobbold SP; Hale G; Clark MR; Waldmann H
Prog Clin Biol Res; 1990; 333():139-51; discussion 152-4. PubMed ID: 2308978
[TBL] [Abstract][Full Text] [Related]
17. Engraftment of marrow allografts treated with Campath-1 monoclonal antibodies.
Naparstek E; Delukina M; Or R; Nagler A; Kapelushnik J; Varadi G; Strauss N; Cividalli G; Aker M; Brautbar C; Waldmann H; Hale G; Slavin S
Exp Hematol; 1999 Jul; 27(7):1210-8. PubMed ID: 10390197
[TBL] [Abstract][Full Text] [Related]
18. Positive selection of hematopoietic CD34+ stem cells provides 'indirect purging' of CD34- lymphoid cells and the purging efficiency is increased by anti-CD2 and anti-CD30 immunotoxins.
Lemoli RM; Tazzari PL; Fortuna A; Bolognesi A; Gulati SC; Stirpe F; Tura S
Bone Marrow Transplant; 1994 Apr; 13(4):465-71. PubMed ID: 7517259
[TBL] [Abstract][Full Text] [Related]
19. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS
Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507
[TBL] [Abstract][Full Text] [Related]
20. Excessive T cell depletion of peripheral blood stem cells has an adverse effect upon outcome following allogeneic stem cell transplantation.
Chakraverty R; Robinson S; Peggs K; Kottaridis PD; Watts MJ; Ings SJ; Hale G; Waldmann H; Linch DC; Goldstone AH; Mackinnon S
Bone Marrow Transplant; 2001 Nov; 28(9):827-34. PubMed ID: 11781642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
